Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis - PubMed (original) (raw)
Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis
P Iozzo et al. Am J Physiol Endocrinol Metab. 2001 May.
Free article
Abstract
Although chronic hyperinsulinemia has been shown to induce insulin resistance, the basic cellular mechanisms responsible for this phenomenon are unknown. The present study was performed 1) to determine the time-related effect of physiological hyperinsulinemia on glycogen synthase (GS) activity, hexokinase II (HKII) activity and mRNA content, and GLUT-4 protein in muscle from healthy subjects, and 2) to relate hyperinsulinemia-induced alterations in these parameters to changes in glucose metabolism in vivo. Twenty healthy subjects had a 240-min euglycemic insulin clamp study with muscle biopsies and then received a low-dose insulin infusion for 24 (n = 6) or 72 h (n = 14) (plasma insulin concentration = 121 +/- 9 or 143 +/- 25 pmol/l, respectively). During the baseline insulin clamp, GS fractional velocity (0.075 +/- 0.008 to 0.229 +/- 0.02, P < 0.01), HKII mRNA content (0.179 +/- 0.034 to 0.354 +/- 0.087, P < 0.05), and HKII activity (2.41 +/- 0.63 to 3.35 +/- 0.54 pmol x min(-1) x ng(-1), P < 0.05), as well as whole body glucose disposal and nonoxidative glucose disposal, increased. During the insulin clamp performed after 24 and 72 h of sustained physiological hyperinsulinemia, the ability of insulin to increase muscle GS fractional velocity, total body glucose disposal, and nonoxidative glucose disposal was impaired (all P < 0.01), whereas the effect of insulin on muscle HKII mRNA, HKII activity, GLUT-4 protein content, and whole body rates of glucose oxidation and glycolysis remained unchanged. Muscle glycogen concentration did not change [116 +/- 28 vs. 126 +/- 29 micromol/kg muscle, P = nonsignificant (NS)] and was not correlated with the change in nonoxidative glucose disposal (r = 0.074, P = NS). In summary, modest chronic hyperinsulinemia may contribute directly (independent of change in muscle glycogen concentration) to the development of insulin resistance by its impact on the GS pathway.
Similar articles
- Regulation of hexokinase II expression in human skeletal muscle in vivo.
Vogt C, Ardehali H, Iozzo P, Yki-Järvinen H, Koval J, Maezono K, Pendergrass M, Printz R, Granner D, DeFronzo R, Mandarino L. Vogt C, et al. Metabolism. 2000 Jun;49(6):814-8. doi: 10.1053/meta.2000.6245. Metabolism. 2000. PMID: 10877213 Clinical Trial. - Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activity.
Ebeling P, Bourey R, Koranyi L, Tuominen JA, Groop LC, Henriksson J, Mueckler M, Sovijärvi A, Koivisto VA. Ebeling P, et al. J Clin Invest. 1993 Oct;92(4):1623-31. doi: 10.1172/JCI116747. J Clin Invest. 1993. PMID: 8408617 Free PMC article. - Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.
Christiansen E, Vestergaard H, Tibell A, Hother-Nielsen O, Holst JJ, Pedersen O, Madsbad S. Christiansen E, et al. Diabetes. 1996 Sep;45(9):1267-75. doi: 10.2337/diab.45.9.1267. Diabetes. 1996. PMID: 8772733
Cited by
- Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity.
Petersen MC, Smith GI, Palacios HH, Farabi SS, Yoshino M, Yoshino J, Cho K, Davila-Roman VG, Shankaran M, Barve RA, Yu J, Stern JH, Patterson BW, Hellerstein MK, Shulman GI, Patti GJ, Klein S. Petersen MC, et al. Cell Metab. 2024 Apr 2;36(4):745-761.e5. doi: 10.1016/j.cmet.2024.03.002. Cell Metab. 2024. PMID: 38569471 - The WCIRDC 2023: Concepts of insulin resistance.
Bloomgarden Z. Bloomgarden Z. J Diabetes. 2024 Mar;16(3):e13552. doi: 10.1111/1753-0407.13552. J Diabetes. 2024. PMID: 38516866 Free PMC article. No abstract available. - Weight versus weight-independent effects of Roux-en-Y gastric bypass on type 2 diabetes.
Klein S, Seeley RJ. Klein S, et al. Nat Metab. 2023 Jun;5(6):912-914. doi: 10.1038/s42255-023-00823-w. Nat Metab. 2023. PMID: 37337127 Free PMC article. - Diabetes-free survival among living kidney donors and non-donors with obesity: A longitudinal cohort study.
Killian AC, Reed RD, McLeod MC, MacLennan PA, Kumar V, Pittman SE, Maynor AG, Stanford LA, Baker GA, Schinstock CA, Silkensen JR, Roll GR, Segev DL, Orandi BJ, Lewis CE, Locke JE. Killian AC, et al. PLoS One. 2022 Nov 18;17(11):e0276882. doi: 10.1371/journal.pone.0276882. eCollection 2022. PLoS One. 2022. PMID: 36399462 Free PMC article. - Obesity Is Associated With Increased Basal and Postprandial β-Cell Insulin Secretion Even in the Absence of Insulin Resistance.
van Vliet S, Koh HE, Patterson BW, Yoshino M, LaForest R, Gropler RJ, Klein S, Mittendorfer B. van Vliet S, et al. Diabetes. 2020 Oct;69(10):2112-2119. doi: 10.2337/db20-0377. Epub 2020 Jul 10. Diabetes. 2020. PMID: 32651241 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous